Soft-tissue Sarcoma: Clinical Trials

2 trials for Soft-tissue Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2
Phase 22Unknown 2

Follow Soft-tissue Sarcoma: new trials by email Literature Review of Soft-tissue Sarcoma trials Research Report on Soft-tissue Sarcoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
Phase 1 : Regorafenib, Phase 1 : Avelumab, Phase 2 : Regorafenib - Colorectal Cancer Not MSI-H or MMR-deficient, GIST
Phase 1 / Phase 2UnknownInstitut BergoniƩ7472018-05-042023-03-03
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
Cyclophosphamide and JX-594 dose escalation, Cyclophosphamide and JX-594, Cyclophosphamide - Solid Tumors, Soft-tissue Sarcoma
Phase 1 / Phase 2UnknownInstitut BergoniƩ1972015-09-182022-02-02

Narrower conditions

Sarcoma (2)  ·  Biliary Tract Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Gastro-enteropancreatic neuroendocrine tumor (1)  ·  Mesothelioma, Malignant (1)  ·  Neoplasm Metastasis (1)  ·  Stomach Neoplasms (1)  ·  Tertiary Lymphoid Structures (1)  ·  Thyroid Neoplasms (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Turcot syndrome (1)

Broader conditions

Breast Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Adenocarcinoma (1)  ·  Adenoma (1)  ·  Biliary Tract Diseases (1)  ·  Breast Neoplasms (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Digestive System Diseases (1)

Interventions

Clinical Trials, Phase II as Topic (1)  ·  Cyclophosphamide (1)  ·  avelumab (1)  ·  regorafenib (1)

Sponsors

Institut BergoniƩ (2)

Countries

France (2)

Results publications

PMID 34965951, PMID 34998048, PMID 40204996, PMID 40579407

NIH funding

2014 (1), 2016 (1)